Presenter(s): Kathleen Brady, MD, PhD, Distinguished Professor, Medical University of South Carolina

Target Audience: This activity is designed for nurses, physicians, physician assistants, psychiatrists, and interprofessional teams. This activity is accredited for physicians.

Webinar Description: Exacerbated by the COVID-19 pandemic, the Opioid Epidemic in the United States is a dangerous reality that affects all demographics. In this presentation, gender differences in opioid use disorders will be discussed from an epidemiologic perspective. Understanding the differences in trends by gender can help clinicians treat the patient, rather than treating the condition. Neurobiological and social determinants will also be reviewed as the differences vary greatly by gender. Finally, treatment implications will be discussed so we can better understand the impact of tailored OUD treatment.

Educational Objectives:

• Apply the epidemiologic differences in the prevalence of OUD to your practice setting.
• Identify the gender differences in neurobiology of OUD when treating patients.
• Evaluate the patient treatment outcomes based on gender.

Credit Designations Available: 1.0 AMA PRA Category 1 Credit™ for physicians

Continuing Education Information:

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Psychiatric Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support for the Program:
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.